Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer

Expert Review of Anticancer Therapy

Volumn 9, Issue 10, 2009, Pages 1467-1472

  Duffy, Stephen W ^a   Raji, Olaide Y ^b   Agbaje, Olorunsola F ^c   Allgood, Prue C ^a   Cassidy, Adrian ^b   Field, John K ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Computed tomography; Lung cancer; Risk model; Screening; Trial design

Indexed keywords

CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; HEALTH CARE PLANNING; HIGH RISK POPULATION; HUMAN; LUNG CANCER; PREDICTION; REVIEW; RISK BENEFIT ANALYSIS; STATISTICAL MODEL;

HUMANS; LUNG NEOPLASMS; MASS SCREENING; MODELS, STATISTICAL; PROGRAM DEVELOPMENT; RISK; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350591894     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/ERA.09.87     Document Type: Review

References (20)

1. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat. Med. 23, 1111-1130 (2004). (Pubitemid 38477070)
2. Park Y, Freeman AM, Gail MH et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J. Clin. Oncol. 27, 694-698 (2009).
3. Neuhauser HK, Ellert U, Kurth BM. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998. Eur. J. Cardiovasc. Prev. Rehabil. 12, 442-450 (2005).
4. Field JK, Duffy SW. Lung cancer screening: the way forward. Br. J. Cancer 99, 557-562 (2008). • Reviews the current information on computed tomography (CT) screening for lung cancer, including the need for assessing the impact of low-dose CT screening and treatment in decreasing lung cancer mortality compared with a control group, as well as accurate estimation of balance of benefits and harms, and determination of the cost-effectiveness of the intervention.
5. van Klaveren RJ, de Koning HJ, Mulshine J, Hirsch FR. Lung cancer screening by spiral CT. What is the optimal target population for screening trials? Lung Cancer 38, 243-252 (2002). •• Provides recommendation for the selection of the optimal target population for lung cancer CT screening based on a combination of risk factors and high-risk populations. (Pubitemid 35341798)
6. Bach PB, Elkin EB, Pastorino U et al. Benchmarking lung cancer mortality rates in current and former smokers. Chest 126, 1742-1749 (2004). •• Presents the development and validation of a risk model for lung cancer death. (Pubitemid 39643974)
7. Spitz MR, Hong WK, Amos CI et al. A risk model for prediction of lung cancer. J. Natl Cancer Inst. 99, 715-726 (2007). •• Presents the development and validation of an absolute risk model for lung cancer.
8. Cassidy A, Myles JP, van Tongeren M et al. The LLP risk model: an individual risk prediction model for lung cancer. Br. J. Cancer 98, 270-276 (2008). •• Presents the development and validation of a risk model for predicting a 5-year absolute risk of lung cancer for an individual with a specific combination of risk factors, including lifestyle and family history factors. (Pubitemid 351161249)
9. Peto R. Influence of dose and duration of smoking on lung cancer rates. In: Tobacco: A Major International Health Hazard. Zaridze D, Peto R (Eds). International Agency for Research on Cancer, Lyon, France 23-33 (1986).
10. Cassidy A, Myles JP, Duffy SW, Liloglou T, Field JK. Family history and risk of lung cancer: age-at-diagnosis in cases and first degree relatives. Br. J. Cancer 95, 1288-1290 (2006). (Pubitemid 44658498)
11. Risch A, Plass C. Lung cancer epigenetics and genetics. Int. J. Cancer 123, 1-7 (2008).
12. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 297, 953-961 (2007). (Pubitemid 46376749)
13. Henschke CI, Yankelevitz D, Smith JP, Miettinen OS. Computed tomography screening for lung cancer. JAMA 298, 514-515 (2007). (Pubitemid 47204946)
14. Black WC. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer 110, 2370-2384 (2007).
15. Chien CR, Chen THH. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int. J. Cancer 122, 2594-2599 (2008). • Provides current information on CT screening for lung cancer and presents mathematical models for projecting lung cancer mortality reduction attributed to screening.
16. Coleman MP, Rachet B, Woods LM et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br. J. Cancer 90, 1367-1373 (2004).
17. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N. Engl. J. Med. 355, 1763-1771 (2006).
18. Marcus PM, Bergstralh EJ, Fagerstrom RM et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J. Natl Cancer Inst. 92, 1308-1316 (2000).
19. Field JK. Lung cancer risk models come of age. Cancer Prev. Res. 1, 226-228 (2008).
20. UK Lung Cancer Screening Trial (UKLS) - Feasibility study and protocol development www.hta.ac.uk/1752